Vaccines still prove effective on Delta variantCOVID-19 vaccines will prevent ER visits and hospitalizations caused by the Delta variant too, confirms a new national US study Gearing up for third vaccine doses for the immunocompromisedEligible patients will require a letter from their physician to receive a third dose, but pharmacists can assist in identifying candidates Getting a COVID-19 vaccine may be good for mental health New research is showing that even a first dose can ease mental distress Gearing up for third vaccine doses for the immunocompromised Eligible patients will require a letter from their physician to receive a third dose, but pharmacists can assist in identifying candidates Quiz: How much do you know about PrEP and HIV? How much do you know about pre-exposure prophylaxis (PrEP) to prevent HIV in people at high risk for the infection? Cross-country snapshot of unvaccinated Canadian healthcare workers Many are not immune to COVID-19 conspiracy theories and misinformation. Pfizer COVID-19 vaccine unlikely to cause relapse of Guillain-Barré syndrome Study suggests minimal risk of relapse when Pfizer-BioNTech mRNA COVID-19 vaccine is given to patients with a history of GBS. Ivermectin: efficacy and safety data lacking for COVID-19 prevention or treatment Health Canada advises consumers not use veterinary or human dosage forms of ivermectin to prevent or treat COVID-19. Vaccine hesitancy highest in Alberta, racialized groups at rollout's start: survey The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health–Americas. J&J: Potential HIV vaccine falls short in mid stage study The study in sub-Saharan Africa involved about 2,600 women who were deemed to be at high risk of acquiring HIV, which causes AIDS. First Previous 70 71 72 73 74 Next Last
